Market Cap: $280.25M
AP
Amarin Corporation plc
AMRN
NASDAQ (NASDAQ Global Market)USD
Market Cap: $280.25M
Amarin Corp: Poised for Growth Through Innovation and Strategic Expansion In its recent Q4 earnings report, Amarin Corp showcases a robust financial performance and strategic developments pivotal to i…
Amarin Corp. Solidifies Market Position with Strategic Developments and Strong Q4 Performance Amarin Corp., a key player in the cardiovascular therapy market, reports a strong financial performance fo…
Amarin Corp's Promising Growth in Cardiovascular Therapies Amarin Corp is currently experiencing significant growth within the cardiovascular therapeutic market, primarily driven by the increasing sal…
Amarin Reports Strong Financial Results, Underlining Market Resilience Amarin, a prominent player in the biopharmaceutical industry, announces its latest financial results, showcasing a significant up…
Amarin Corp's Upcoming Earnings Call: A Crucial Moment for Cardiovascular Solutions Amarin Corp (NASDAQ:AMRN) is set to unveil its quarterly earnings report on October 29, 2025, an event that holds si…
Amarin Corp Prepares for Key Earnings Report Amid Competitive Landscape Amarin Corp is set to release its quarterly earnings report on October 29, 2025, and the upcoming announcement is poised to be a…
Amarin Corporation's Strategic Expansion into European Markets Amarin Corporation Plc (AMRN) has solidified its commitment to enhancing cardiovascular health with a significant exclusive license and s…